EP-1237: Heart dose as a risk factor for dyspnea worsening after multimodality treatment for NSCLC and MPM. (May 2017) - Botticella, A.; Billiet, C.; Defraene, G.; Peeters, S.; Draulans, C.; Nafteux, P.; Vansteenkiste, J.; Nackaerts, K.; Dooms, C.; Deroose, C.; Coolen, J.; De Ruysscher, D.